NCT03503773View on ClinicalTrials.gov

The TARGET BP OFF-MED Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

January 10, 2024

Conditions
HypertensionHypertension,Essential
Interventions
DRUG

Alcohol

Alcohol is directly infused/delivered to the adventitial and periadventitial space of the renal arteries

OTHER

Sham control

endovascular, renal angiography

Trial Locations (4)

1200

Cliniques Universitaires Saint-Luc, Brussels

66421

Universitätsklinikum des Saarlandes, Homburg/Saar

Unknown

Clinique Pasteur Toulouse, Toulouse

EC1M 6BQ

NIHR Barts Cardiovascular Biomedical Research Unit, London

Sponsors
All Listed Sponsors
lead

Ablative Solutions, Inc.

INDUSTRY

NCT03503773 - The TARGET BP OFF-MED Trial | Biotech Hunter | Biotech Hunter